[Market Focus] Inventera Surges 140% on First Day of KOSDAQ Listing
Inventera, a company specializing in the development of nanomedicines, is showing a remarkable surge of over 140% on its first day of KOSDAQ trading.
As of 9:13 a.m. on April 2, 2026, Inventera was trading at 40,000 won, up 23,400 won (140.96%) from its initial public offering price of 16,600 won.
The core of Inventera lies in its Invinity platform technology, which utilizes nanostructures. The company is validating this technology through clinical trials in both Korea and the United States, and it plans to generate revenue next year by launching a new nano-MRI contrast agent. By 2029, Inventera aims for 3.76 billion won in sales and 2.22 billion won in operating profit through domestic and overseas product sales as well as technology licensing fees.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
During the public subscription for general investors held on March 23-24, Inventera posted a competition rate of 1,913.44 to 1, with deposits for subscription amounting to 4.6851 trillion won. In the institutional investor demand forecast, the offering price was set at the top end of the desired range, 16,600 won, with an institutional competition rate of 1,328.28 to 1.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.